Evidence map›Paper›PMID 30381375›Full record

ArticleBlood2018

Nrf2 regulates CD4

Jennifer J Tsai, Enrico Velardi, Yusuke Shono, Kimon V Argyropoulos, Amanda M Holland, Odette M Smith, Nury L Yim, Uttam K Rao, Fabiana M Kreines, Sophie R Lieberman and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Jennifer J TsaiDepartment of Immunology, and.ORCID 0000-0002-9267-4584
Enrico VelardiDepartment of Immunology, and.ORCID 0000-0001-8383-0453
Yusuke ShonoDepartment of Immunology, and.ORCID 0000-0002-0459-1659
Kimon V ArgyropoulosDepartment of Immunology, and.ORCID 0000-0003-1510-5887
Amanda M HollandDepartment of Immunology, and.
Odette M SmithDepartment of Immunology, and.
Nury L YimDepartment of Immunology, and.
Uttam K RaoDepartment of Immunology, and.
Fabiana M KreinesDepartment of Immunology, and.
Sophie R LiebermanDepartment of Immunology, and.
Lauren F YoungDepartment of Immunology, and.
Amina LazrakDepartment of Immunology, and.
Salma YoussefDepartment of Immunology, and.
Ya-Yuan FuDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Chen LiuDepartment of Pathology and Laboratory Medicine, Rutgers New Jersey Medical School and Rutgers Robert Wood Johnson Medical School, Newark, NJ.
Cecilia LezcanoDepartment of Pathology, Brigham and Women's Hospital, Boston, MA.
George F MurphyDepartment of Pathology, Brigham and Women's Hospital, Boston, MA.
Il-Kang NaDepartment of Immunology, and.
Robert R JenqDepartment of Immunology, and.
Alan M HanashDepartment of Immunology, and.
Jarrod A DudakovDepartment of Immunology, and.ORCID 0000-0001-6220-5632
Marcel R M van den BrinkDepartment of Immunology, and.ORCID 0000-0003-0696-4401
Memorial Sloan Kettering Cancer Center · USBrigham and Women's Hospital · USState University of New York · USRutgers, The State University of New Jersey · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAMER, ERIC G. · 1985 to 2023
$59.0M
Thymic and Peripheral Aspects of T Cell Aging and RejuvenationP01AG052359 · NIA · UNIVERSITY OF ARIZONA · PI Laura P. Hale · 2017 to 2026
$23.5M
The role of intestinal microbiota in graft-versus-host diseaseR01CA228308 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Philip L Lorenzi, Marcel R M van den Brink · 2018 to 2026
$5.2M
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1R01HL123340 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CADWELL, KEN HASHIGIWA, VAN DEN BRINK, MARCEL R M · 2015 to 2022
$5.2M
Discriminating EGFR function in T cells and epithelium during immune-mediated tissue damageR01HL146338 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI Alan M Hanash · 2018 to 2026
$4.8M
Regulation of the intestinal stem cell compartment after hematopoietic transplantationR01HL125571 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI Alan M Hanash · 2015 to 2026
$4.4M
The role of intestinal microbiota in graft-versus-host diseaseR01CA228358 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VAN DEN BRINK, MARCEL R M · 2018 to 2022
$2.6M
IL-22 in epithelial regeneration after allogeneic transplantK08HL115355 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI HANASH, ALAN M · 2012 to 2016
$719k
NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA228308NCI NIH HHS R01 CA228358NHLBI NIH HHS K08 HL115355NHLBI NIH HHS R01 HL123340NHLBI NIH HHS R01 HL125571NHLBI NIH HHS R01 HL146338NIA NIH HHS P01 AG052359
6 · The paper itself

Abstract

Nuclear factor erythroid-derived 2-like 2 (Nrf2) is a ubiquitously expressed transcription factor that is well known for its role in regulating the cellular redox pathway. Although there is mounting evidence suggesting a critical role for Nrf2 in hematopoietic stem cells and innate leukocytes, little is known about its involvement in T-cell biology. In this study, we identified a novel role for Nrf2 in regulating alloreactive T-cell function during allogeneic hematopoietic cell transplantation (allo-HCT). We observed increased expression and nuclear translocation of Nrf2 upon T-cell activation in vitro, especially in CD4

Indexed as

Hematopoietic Stem Cell TransplantationLymphocyte ActivationAcute DiseaseAllograftsAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesGraft vs Host DiseaseMiceMice, KnockoutNeoplasms, ExperimentalNF-E2-Related Factor 2Nfe2l2 protein, mouseNF-E2-Related Factor 2

Identifiers

PMID30381375
PMCPMC6307985
OpenAlexW2899102069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.